10x Genomics, Inc. (TXG) Financials

TXG Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 922.9 million 204.1 million
2023-12-31 965.1 million 224.1 million
2023-09-30 948.5 million 203.3 million
2023-06-30 989.6 million 196.3 million

TXG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -18.6 million 36.1 million
2023-12-31 22.3 million 38.9 million
2023-09-30 -40.7 million 40.2 million
2023-06-30 -36.9 million 45.7 million

TXG Net Income

No data available :(

TXG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 371.8 million - 92.2 million
2023-12-31 388.7 million - 95.4 million
2023-09-30 356.9 million - 98.5 million
2023-06-30 391.4 million - 99.6 million

TXG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 119.4 billion
2023-12-31 118.6 million
2023-09-30 117.7 million
2023-06-30 116.7 million

TXG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 2.9 million 68.6 million 85.8 million -
2023-12-31 3.5 million 55.6 million 82.8 million 3.3 million
2023-09-30 15.4 million 107.9 million 82.4 million -
2023-06-30 25.4 million 71.5 million 91.5 million -

TXG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 141.0 million 48.1 million
2023-12-31 184.0 million 77.9 million
2023-09-30 153.6 million 58.1 million
2023-06-30 146.8 million 47.2 million

TXG

Price: $27.48

52 week price:
24.60
63.57

Earnings Per Share: -2.18 USD

P/E Ratio: -22.71

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Volume: 10738

Market Capitalization: 3.2 billion

Links: